By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the important features of self-archiving policy of Bentham Science journals:
Authors can deposit the first draft of a submitted article on their personal websites, their institution’s repositories or any non-commercial repository for personal use, internal institutional use or for permitted scholarly posting.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal websites, their institution’s repository or any non-commercial repository such as PMC, arXiv after 12 MONTHS of publication on the journal website. In addition, an acknowledgement must be given to the original source of publication and a link should be inserted to the published article on the journal's/publisher’s website.
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors are allowed the archiving of published version of manuscripts in an institutional repository after the mandatory embargo period. Authors should first contact the Editorial Office of the journal for information about depositing a copy of the manuscript to a repository. Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL PUBLISHED VERSION of manuscripts.
The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/openurl/content.php?genre=article&doi=[insert DOI].”
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS category. Authors are allowed deposition of such articles on institutional, non-commercial repositories and personal websites immediately after publication on the journal website.
Dimitra Hadjipavlou-Litina Aristotle University of Thessaloniki Thessaloniki Greece
Prof. D. Hadjipavlou-Litina received her Ph.D. in Pharmacy at the Aristotle University of Thessaloniki, Greece under the supervision of Prof. P.N. Kourounakis. She was promoted to full professor in 2009. Her research interests involve synthesis and pharmacochemical studies on anti-inflammatory and antioxidant agents, on inhibitors of enzymes implicated in the inflammation and in the coagulation process in general, as well as the correlation of inflammation with cancer, the theoretical and experimental calculation of physicochemical parameters implicated in biological response, the relationship between structure and activity (use of Computational Chemistry in Drug Design) and analysis and comparative study of Quantitative Structure/Activity Relationships (QSAR) of various categories of drugs and bioactive molecules with the aim of commercially available calculation programs. Her research has resulted in the publication of over 210 peer-reviewed articles, over 5400 citations. She is in the editorial board of 7 journals and the editor in two. She has been awarded by the American Chemical Society twice for most assessed research published papers (Hadjipavlou-Litina D, Garg R, Hansch C. Chem. Rev. 2004, 104(9): 3751-94; Michaelidou AS, Hadjipavlou-Litina D. Chem. Rev. 2005,105(9): 3235-71).